Healthcare, Pharma & Life Sciences

BPI Urges EU to Make Drug Supply Security Binding in PPA

Image
BPI Urges EU to Make Drug Supply Security Binding in PPA

Berlin – – September 15, 2026 -- The European Commission today unveiled the EU Public Procurement Act (PPA), a comprehensive proposal to modernize European procurement law, drawing an immediate response from Germany's pharmaceutical industry association BPI.

BPI demands supply security as binding procurement criterion

Dr. Kai Joachimsen, Chief Executive of the BPI (Bundesverband der Pharmazeutischen Industrie), said the European Commission must make supply security a mandatory guideline for pharmaceutical procurement. He stated the goal must be supply sovereignty, achieved through strong production capacities in Europe and diversified, resilient supply chains.

Icentia Names Sanjay Voleti CEO, Targets US Market Growth

Image
Icentia Names Sanjay Voleti CEO, Targets US Market Growth

Quebec City – September 15, 2026 -- Icentia has appointed Sanjay Voleti as Chief Executive Officer, succeeding co-founder Pierre Paquet, with a mandate to expand the cardiac diagnostics company's commercial footprint in the United States.

Icentia Names Ex-AliveCor Executive Sanjay Voleti as New CEO

Image
Icentia Names Ex-AliveCor Executive Sanjay Voleti as New CEO

Quebec City – September 15, 2026 -- Icentia has appointed Sanjay Voleti as President and CEO, tasking the digital health veteran with accelerating the cardiac diagnostics company's commercial expansion in the United States.

Voleti succeeds co-founder Pierre Paquet after the company built operations across four countries

Voleti replaces co-founder Pierre Paquet, who led Icentia from its founding as a Canadian health-tech startup into an international operator with a presence in Canada, the United Kingdom, Ireland and the United States. Paquet said the company's CardioSTAT platform has become a reference point in continuous ambulatory ECG recording and that the time had come to bring in a leader experienced in scaling technology companies internationally.

AEYE Health's FDA-Cleared AI Hits 99% Imageability in 1,200-Patient Trial

Image
AEYE Health's FDA-Cleared AI Hits 99% Imageability in 1,200-Patient Trial

New York – September 15, 2026 -- AEYE Health published peer-reviewed results in Frontiers in Digital Health confirming its FDA-cleared AEYE-DS system achieved over 99% imageability across three prospective, controlled pivotal trials involving more than 1,200 diabetic patients.

Trial data validate the clinical foundation behind AEYE-DS's two FDA clearances

The study, covering trials AEYE-1, AEYE-2 and AEYE-3, benchmarked the autonomous AI against reading center multi-expert clinical review. AEYE-DS requires only a single image per eye, works with both portable handheld and tabletop cameras, and rarely requires pupil dilation -- making it the only FDA-cleared portable autonomous solution for diabetic retinopathy on the market, according to the company.

BRG Names Jamie LaGuardia-Frie Managing Director in Healthcare Practice

New York – September 14, 2026 -- BRG has appointed Jamie LaGuardia-Frie as managing director in its Healthcare practice, tasking her with leading business development and client strategy for the firm's Healthcare Advisory team.

LaGuardia-Frie brings more than 20 years of healthcare consulting and technology experience

Based in New York, she joins after serving as managing director and chief commercial officer for Alvarez & Marsal's Health Industry Group. She spent nearly a decade at Guidehouse, holding roles including Health Growth Leader and East Regional Market Leader for Commercial Healthcare. Earlier in her career, she worked in consulting, business development and technology at Accretive Health and Allscripts.

Neurent Medical Secures €25M Debt Facility From Claret Capital

Image
Neurent Medical Secures €25M Debt Facility From Claret Capital

Galway, Ireland – – September 14, 2026 -- Neurent Medical has secured a €25 million growth debt financing facility from Claret Capital Partners to accelerate commercial expansion of its NEUROMARK® System for chronic rhinitis treatment.

Debt facility follows €62.5 million Series C round completed earlier in 2026

The new €25 million facility builds on Neurent Medical's €62.5 million Series C financing round, which closed earlier this year. The combined capital reinforces the company's position in minimally invasive treatments for chronic inflammatory sinonasal diseases.

Combined Microneedling-Exosome Protocol Shows Melasma Improvement in Skin of Color

Image
Combined Microneedling-Exosome Protocol Shows Melasma Improvement in Skin of Color

Louisville, Ky. – September 14, 2026 -- Induction Therapies and Collagen P.I.N., in partnership with aesthetic physician Dr. Shino Bay Aguilera, released new clinical findings on a treatment protocol combining Collagen P.I.N. microneedling with PRX8, a plant-derived exosome serum, for melasma in a patient with Fitzpatrick skin type V.

Patient shows sustained improvement after four treatments over eight weeks

The case involved a woman with longstanding facial melasma who had previously used topical hydroquinone and tranexamic acid without full resolution. She underwent four Collagen P.I.N. treatments over an eight-week period, with TRUExosomes PRX8 Plant-Exo Stimulation Serum applied after each session and daily sunscreen maintained throughout.

Visible improvement in the appearance of melasma was observed across the treatment course and persisted at the two-week follow-up after the final treatment, with no adverse reactions reported.

ElectroWire's LightningWire Completes First Six Cardiac Cases, Zero Complications

Image
ElectroWire's LightningWire Completes First Six Cardiac Cases, Zero Complications

Lexington, S.C. – September 14, 2026 -- ElectroWire Medical's FDA-cleared LightningWire Transseptal Puncture System has completed its first six clinical cases at Spartanburg Medical Center in Spartanburg, South Carolina, with zero complications reported.

Six procedures spanned mitral repair, LAA occlusion and pulsed field ablation

The case mix included one mitral valve repair, one left atrial appendage occlusion, and four pulsed field ablations, performed by structural interventional cardiologist Dr. Nalin Srivastava and cardiac electrophysiologist Dr. David Rodak. The team used four different transseptal introducers and two different electrosurgical generators during the cases, testing the device's compatibility with equipment already in operator inventories.

BioMarin's VOXZOGO Hits Primary Endpoint in Phase 3 Hypochondroplasia Study

Image
BioMarin's VOXZOGO Hits Primary Endpoint in Phase 3 Hypochondroplasia Study

San Rafael, Calif. – September 14, 2026 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) reported that its Phase 3 CANOPY-HCH-3 trial of VOXZOGO (vosoritide) met its primary endpoint in children with hypochondroplasia, with results published in NEJM Evidence and presented at the European Society for Paediatric Endocrinology 2026 Annual Meeting.

MacroHealth Names Erica Tingley as Chief Financial Officer

Image
MacroHealth Names Erica Tingley as Chief Financial Officer

Kirkland – September 14, 2026 -- MacroHealth, a marketplace platform connecting healthcare payers and plan administrators with vendor partners, has appointed Erica Tingley as Chief Financial Officer to oversee financial and operational scaling as the company expands its service categories.

Tingley brings 25 years of healthcare finance experience to the CFO role

Tingley's background spans investment banking, mergers and acquisitions, corporate finance and operations. She most recently served as President and CFO of Knowtion Health, a revenue cycle management partner to health systems, where she managed both financial strategy and solution delivery. Before that role, she was COO and CFO of Bluesight, where she worked on driving consistent, profitable growth. Earlier in her career, she held positions at The Advisory Board Company and Bank of America Merrill Lynch.